These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 410110)

  • 21. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.
    Sroczynski G; Esteban E; Conrads-Frank A; Schwarzer R; Mühlberger N; Wright D; Zeuzem S; Siebert U
    Eur J Public Health; 2009 Jun; 19(3):245-53. PubMed ID: 19196737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The menace of mass screening.
    Bergman AB
    Am J Public Health; 1977 Jul; 67(7):601-2. PubMed ID: 406803
    [No Abstract]   [Full Text] [Related]  

  • 23. A cost analysis of community screening for diabetes in the central Wisconsin Medicare population (results from the MetaStar pilot project in Wausau).
    Lee DS; Remington P; Madagame J; Blustein J
    WMJ; 2000 Jun; 99(3):39-43. PubMed ID: 10927980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
    Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
    J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health and economic benefits of well-designed evaluations: some lessons from evaluating neuroblastoma screening.
    Soderstrom L; Woods WG; Bernstein M; Robison LL; Tuchman M; Lemieux B
    J Natl Cancer Inst; 2005 Aug; 97(15):1118-24. PubMed ID: 16077069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status and future role of health screening.
    North AF
    South Med J; 1977 Oct; 70(10):1232-6. PubMed ID: 410110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC
    In Vivo; 1994; 8(3):423-7. PubMed ID: 7803728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention. How much harm? How much benefit? 2. Ten potential pitfalls in determining the clinical significance of benefits.
    Marshall KG
    CMAJ; 1996 Jun; 154(12):1837-43. PubMed ID: 8653643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening in liver disease: report of an AASLD clinical workshop.
    Adams PC; Arthur MJ; Boyer TD; DeLeve LD; Di Bisceglie AM; Hall M; Levin TR; Provenzale D; Seeff L
    Hepatology; 2004 May; 39(5):1204-12. PubMed ID: 15122748
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.